[1]栗竞 单冬凯 王凡.基于冠状动脉CT血管造影的功能学评价技术[J].心血管病学进展,2020,(8):812-816.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.008]
 LI JingSHAN DongkaiWANG Fan.Functional Evaluation Technology Based on Coronary CT Angiography[J].Advances in Cardiovascular Diseases,2020,(8):812-816.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.008]
点击复制

基于冠状动脉CT血管造影的功能学评价技术()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年8期
页码:
812-816
栏目:
综述
出版日期:
2020-08-25

文章信息/Info

Title:
Functional Evaluation Technology Based on Coronary CT Angiography
作者:
栗竞1 单冬凯2 王凡3
 (1.中国人民解放总医院京西医疗区西山门诊部,北京 100091;2.中国人民解放军总医院第一医学中心,北京 100853;3.中国人民解放军总医院第二医学中心,北京 100853)
Author(s):
LI Jing1SHAN Dongkai2WANG Fan3
Beijing West Medical District,Chinese PLA General Hospital,Beijing 100091, China; 2.The First Medical Center,Chinese PLA General Hospital,Beijing 100853, China; 3.The Second Medical Center,Chinese PLA General Hospital,Beijing 100853, China)
关键词:
冠心病心肌灌注血流储备分数
Keywords:
Coronary artery disease Myocardial perfusion Fractional flow reserve
DOI:
10.16806/j.cnki.issn.1004-3934.2020.08.008
摘要:
冠状动脉CT血管造影是临床中常用的稳定性冠心病诊断技术。单纯依靠冠状动脉CT血管造影确诊的解剖学病变并不足以解释部分冠心病的血流动力学异常,近年来研究人员提出了基于冠状动脉CT血管造影的心肌灌注和血流储备分数技术,从功能学角度弥补了单纯冠状动脉CT血管造影诊断的不足。现从技术原理、研究证据和临床应用等方面对此两种新技术进行简要总结。
Abstract:
Coronary computed tomographic angiography(CCTA) is the widely used diagnostic technology for stable coronary artery disease(CAD).Because it is insufficient for interpreting of hemodynamic abnormality of CAD only depending on CCTA,myocardial perfusion and fractional flow reserve based on CCTA have developed in recent years,which make up for the limitation of CCTA in detecting functional ischemia.This review summarizes the two new technologies on technical principle,research evidence and clinical application

参考文献/References:


[1] Douglas PS,Hoffmann U,Patel MR,et al.Outcomes of anatomical versus functional testing for coronary artery disease[J].N Engl J Med,2015,372(14):1291-1300.

[2] SCOT-HEART investigators.CT coronary angiography in patients with suspected angina due to coronary heart disease(SCOT-HEART):an open-label,parallel-group,multicentre trial [published correction appears in Lancet.2015 Jun 13;385(9985):2354][J].Lancet,2015,385(9985):2383-2391.

[3] Rossi A,Merkus D,Klotz E,et al.Stress myocardial perfusion:imaging with multidetector CT[J].Radiology,2014,270(1):25-46.

[4] Mehra VC,Valdiviezo C,Arbab-Zadeh A,et al.A stepwise approach to the visual interpretation of CT-based myocardial perfusion[J].J Cardiovasc Comput Tomogr,2011,5(6):357-369.

[5] Yang DH,Kim YH,Roh JH,et al.Stress myocardial perfusion CT in patients suspected of having coronary artery disease:visual and quantitative analysis-validation by using fractional flow reserve[J].Radiology,2015,276(3):715-723.

[6] Ko SM,Choi JW,Song MG,et al.Myocardial perfusion imaging using adenosine-induced stress dual-energy computed tomography of the heart:comparison with cardiac magnetic resonance imaging and conventional coronary angiography[J].Eur Radiol,2011,21(1):26-35.

[7] Kikuchi Y,Oyama-Manabe N,Naya M,et al.Quantification of myocardial blood flow using dynamic 320-row multi-detector CT as compared with 15O-H2O PET[J].Eur Radiol,2014,24(7):1547-1556.

[8] Pelgrim GJ,Dorrius M,Xie X,et al.The dream of a one-stop-shop:Meta-analysis on myocardial perfusion CT[J].Eur J Radiol,2015,84(12):2411-2420.

[9] Rochitte CE,George RT,Chen MY,et al.Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography:the CORE320 study[J].Eur Heart J,2014,35(17):1120-1130.

[10] Pontone G,Andreini D,Guaricci AI,et al.Incremental diagnostic value of stress computed tomography myocardial perfusion with whole-heart coverage CT scanner in intermediate- to high-risk symptomatic patients suspected of coronary artery disease[J].JACC Cardiovasc Imaging,2019,12(2):338-349.

[11] Sorgaard MH,Linde JJ,Kuhl JT,et al.Value of myocardial perfusion assessment with coronary computed tomography angiography in patients with recent acute-onset chest pain[J].JACC Cardiovasc Imaging,2018,11(11):1611-1621.

[12] Andreini D,Mushtaq S,Pontone G,et al.Rationale and design of advantage (additional diagnostic value of CT perfusion over coronary CT angiography in stented patients with suspected in-stent restenosis or coronary artery disease progression) prospective study[J].J Cardiovasc Comput Tomogr,2018,12(5):411-417.

[13] Danad I,Szymonifka J,Schulman-Marcus J,et al.Static and dynamic assessment of myocardial perfusion by computed tomography[J].Eur Heart J Cardiovasc Imaging,2016,17(8):836-844.

[14] Rossi A,Dharampal A,Wragg A,et al.Diagnostic performance of hyperaemic myocardial blood flow index obtained by dynamic computed tomography:does it predict functionally significant coronary lesions?[J].Eur Heart J Cardiovasc Imaging,2014,15(1):85-94.

[15] Lu M,Wang S,Sirajuddin A,et al.Dynamic stress computed tomography myocardial perfusion for detecting myocardial ischemia:a systematic review and meta-analysis[J] .Int J Cardiol,2018,258(325-331.

[16] Meinel FG,Pugliese F,Schoepf UJ,et al.Prognostic value of stress dynamic myocardial perfusion CT in a multicenter population with known or suspected coronary artery disease[J].AJR Am J Roentgenol,2017,208(4):761-769.

[17] van Assen M,De Cecco CN,Eid M,et al.Prognostic value of CT myocardial perfusion imaging and CT-derived fractional flow reserve for major adverse cardiac events in patients with coronary artery disease[J].J Cardiovasc Comput Tomogr,2019,13(3):26-33.

[18] Coenen A,Rossi A,Lubbers MM,et al.Integrating CT myocardial perfusion and CT-FFR in the work-up of coronary artery disease[J].JACC Cardiovasc Imaging,2017,10(7):760-770.

[19] Koo BK,Erglis A,Doh JH,et al.Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms.Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study[J].J Am Coll Cardiol,2011,58(19):1989-1997.

[20] Min JK,Leipsic J,Pencina MJ,et al.Diagnostic accuracy of fractional flow reserve from anatomic CT angiography[J].JAMA,2012,308(12):1237-1245.

[21] Norgaard BL,Leipsic J,Gaur S,et al.Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease:the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography:Next Steps)[J].J Am Coll Cardiol,2014,63(12):1145-1155.

[22] Cook CM,Petraco R,Shun-Shin MJ,et al.Diagnostic accuracy of computed tomography-derived fractional flow reserve:a systematic review [published correction appears in JAMA Cardiol.2017 Nov 1;2(11):1284][J].JAMA Cardiol,2017,2(7):803-810.

[23] Collet C,Miyazaki Y,Ryan N,et al.Fractional flow reserve derived from computed tomographic angiography in patients with multivessel CAD[J].J Am Coll Cardiol,2018,71(24):2756-2769.

[24] Driessen RS,Danad I,Stuijfzand WJ,et al.Comparison of coronary computed tomography angiography,fractional flow reserve,and perfusion imaging for ischemia diagnosis[J].J Am Coll Cardiol,2019,73(2):161-173.

[25] Douglas PS,Pontone G,Hlatky MA,et al.Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs.usual care in patients with suspected coronary artery disease:the prospective longitudinal trial of FFR(CT):outcome and resource impacts study[J].Eur Heart J,2015,36(47):3359-3367.

[26] Douglas PS,De Bruyne B,Pontone G,et al.1-Year outcomes of FFRCT-guided care in patients with suspected coronary disease:the PLATFORM study[J].J Am Coll Cardiol,2016,68(5):435-445.

[27] Fairbairn TA,Nieman K,Akasaka T,et al.Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve:lessons from the ADVANCE Registry[J].Eur Heart J,2018,39(41):3701-3711.

[28] Lee JM,Choi G,Koo BK,et al.Identification of high-risk plaques destined to cause acute coronary syndrome using coronary computed tomographic angiography and computational fluid dynamics[J].JACC Cardiovasc Imaging,2019,12(6):1032-1043.

[29] Piroth Z,Toth GG,Tonino PAL,et al.Prognostic value of fractional flow reserve measured immediately after drug-eluting stent implantation[J].Circ Cardiovasc Interv,2017,10(8):e005233.

[30] Collet C,Katagiri Y,Miyazaki Y,et al.Impact of coronary remodeling on fractional flow reserve[J].Circulation,2018,137(7):747-749.

[31] Collet C,Onuma Y,Andreini D,et al.Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease[J].Eur Heart J,2018,39(41):3689-3698.

[32] Modi BN,Sankaran S,Kim HJ,et al.Predicting the physiological effect of revascularization in serially diseased coronary arteries[J].Circ Cardiovasc Interv,2019,12(2):e007577.

[33] Norgaard BL,Hjort J,Gaur S,et al.Clinical use of coronary CTA-derived FFR for decision-making in stable CAD[J].JACC Cardiovasc Imaging,2017,10(5):541-550.

[34] Norgaard BL,Terkelsen CJ,Mathiassen ON,et al.Coronary CT angiographic and flow reserve-guided management of patients with stable ischemic heart disease[J].J Am Coll Cardiol,2018,72(18):2123-2134.

[35] Schwartz FR,Koweek LM,Norgaard BL.Current evidence in cardiothoracic imaging:computed tomography-derived fractional flow reserve in stable chest pain[J].J Thorac Imaging,2019,34(1):12-17.

相似文献/References:

[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
 DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(8):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
 NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(8):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
 LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(8):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
 YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(8):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
 SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(8):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
 GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(8):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
 DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(8):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[8]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
 CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(8):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[9]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
 YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(8):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[10]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
 GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(8):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]

备注/Memo

备注/Memo:
基金项目:国家老年疾病临床医学研究中心开放课题(NCRCG-PLAGH-2019020)
通讯作者:王凡,E-mail:wangfan7281@sina.com
收稿日期:2020-04-21 
更新日期/Last Update: 2020-11-02